NAFDAC rolls out regulatory framework to ensure quality, efficacy of generic medicines

The National Agency for Food and Drug Administration and Control (NAFDAC) has unveiled a new regulatory framework mandating bioequivalence (BE) studies for all generic medicines in Nigeria, in a decisive move to enhance the quality, safety, and efficacy of pharmaceutical products in the country.The post NAFDAC rolls out regulatory framework to ensure quality, efficacy of generic medicines appeared first on Vanguard News.

Read More